Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E H Scheuermann

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Clinical Pharmacology and Therapeutics|December 5, 2000
Effect of angiotensin II infusion with and without angiotensin II type 1 receptor blockade on nitric oxide metabolism and endothelin in human beings: a placebo-controlled study in healthy volunteersJ Gossmann, R Burkhardt, S Harder, et al.
Clinical Nephrology|January 1, 1992
Effect of recombinant human erythropoietin on iron balance in maintenance hemodialysis: theoretical considerations, clinical experience and consequencesP Grützmacher, T Tsobanelis, P Roth, et al.
Journal of Medical Virology|June 1, 1994
Low correlation of human cytomegalovirus DNA amplification by polymerase chain reaction with cytomegalovirus disease in organ transplant recipientsB Weber, U Nestler, W Ernst, et al.
Klinische Wochenschrift|October 1, 1986
Lipid lowering treatment with bezafibrate in patients on chronic haemodialysis: pharmacokinetics and effectsP Grützmacher, E H Scheuermann, W Siede, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|January 1, 1995
Seroprevalence of HCV, HAV, HBV, HDV, HCMV and HIV in high risk groups/Frankfurt a.M., GermanyB Weber, H Rabenau, A Berger, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Renal allograft survival in patients transfused perioperatively onlyW Fassbinder, U Frei, E H Scheuermann, et al.
Transplantation Proceedings|April 26, 2005
Prospective, multicenter, randomized trial to compare incidence of new-onset diabetes mellitus and glucose metabolism in patients receiving cyclosporine microemulsion versus tacrolimus after de novo kidney transplantationF Vincenti, M Tuncer, M Castagneto, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 10, 2012
Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter studyH H Hirsch, F Vincenti, S Friman, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 10, 2012
A Pneumocystis jirovecii pneumonia outbreak in a single kidney-transplant center: role of cytomegalovirus co-infectionR U Pliquett, A Asbe-Vollkopf, P M Hauser, et al.
Transplantation Proceedings|May 4, 2005
Cyclosporine C2 levels in de novo renal allograft recipients: a German multicenter prospective observational studyW Arns, F Zantvoort, D Abendroth, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Clinical Pharmacology and Therapeutics|December 5, 2000
Effect of angiotensin II infusion with and without angiotensin II type 1 receptor blockade on nitric oxide metabolism and endothelin in human beings: a placebo-controlled study in healthy volunteersJ Gossmann, R Burkhardt, S Harder, et al.
Clinical Nephrology|January 1, 1992
Effect of recombinant human erythropoietin on iron balance in maintenance hemodialysis: theoretical considerations, clinical experience and consequencesP Grützmacher, T Tsobanelis, P Roth, et al.
Journal of Medical Virology|June 1, 1994
Low correlation of human cytomegalovirus DNA amplification by polymerase chain reaction with cytomegalovirus disease in organ transplant recipientsB Weber, U Nestler, W Ernst, et al.
Klinische Wochenschrift|October 1, 1986
Lipid lowering treatment with bezafibrate in patients on chronic haemodialysis: pharmacokinetics and effectsP Grützmacher, E H Scheuermann, W Siede, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|January 1, 1995
Seroprevalence of HCV, HAV, HBV, HDV, HCMV and HIV in high risk groups/Frankfurt a.M., GermanyB Weber, H Rabenau, A Berger, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Renal allograft survival in patients transfused perioperatively onlyW Fassbinder, U Frei, E H Scheuermann, et al.
Transplantation Proceedings|April 26, 2005
Prospective, multicenter, randomized trial to compare incidence of new-onset diabetes mellitus and glucose metabolism in patients receiving cyclosporine microemulsion versus tacrolimus after de novo kidney transplantationF Vincenti, M Tuncer, M Castagneto, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 10, 2012
Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter studyH H Hirsch, F Vincenti, S Friman, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 10, 2012
A Pneumocystis jirovecii pneumonia outbreak in a single kidney-transplant center: role of cytomegalovirus co-infectionR U Pliquett, A Asbe-Vollkopf, P M Hauser, et al.
Transplantation Proceedings|May 4, 2005
Cyclosporine C2 levels in de novo renal allograft recipients: a German multicenter prospective observational studyW Arns, F Zantvoort, D Abendroth, et al.
Pageof 4